Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
This activity is supported by independent medical education grants from Alcon Vision, LLC; Genentech, a member of the Roche Group; IVERIC bio, Inc., an Astellas company; Ocuphire Pharma; Outlook Therapeutics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by independent medical education grants from Alcon Vision, LLC; Genentech, a member of the Roche Group; IVERIC bio, Inc., an Astellas company; Ocuphire Pharma; Outlook Therapeutics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
Activity Description
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes and patient quality of life, yet staying up to date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing needs, "Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases" contains clinical trial summaries written by trainees of the 3rd Annual Retina Summit for Fellows and Residents that took place on September 23 and 24, 2023.
Target Audience
The intended audience for this activity is ophthalmologists, ophthalmology residents, retina fellows, and other healthcare professionals involved in the management of patients with retinal diseases.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Assess diagnostic modalities that can improve the early detection of retinal diseases.
- Describe advances in imaging that can improve the diagnosis, treatment, and monitoring of retinal disorders.
- Examine evidence-based medicine, best practices, and treatment algorithms that can improve the medical management of retinal diseases.
- Recognize how data from key clinical trials can be applied to practice and improve the treatment of retinal vascular disorders.
- Evaluate new evidence regarding the use of multimodal therapeutic regimens in the treatment of retinal vascular disorders.
- Examine evidence-based practices, procedures, and technology that improve the surgical management of retinal disorders.
- Summarize key patient-focused, as well as practice management, processes and procedures that can improve overall care and outcomes.
- Share clinical experiences with expert retina specialists in the field to improve clinical and surgical practice, as well as patient care.
Activity Chair
Rishi P. Singh, MD
Staff Physician and President
Cleveland Clinic Martin Hospitals
Stuart, FL
Professor of Ophthalmology
Lerner College of Medicine
Case Western Reserve University
Cleveland, OH
Faculty
Nikhil Das, MD
Cleveland Clinic Learner College of Medicine
Cleveland, OH
Jonathan Markle, MD
Research Assistant
Center for Ophthalmic Bioinformatics
Cleveland Clinic Learner College of Medicine
Cleveland, OH
Priya Shukla, BS
Medical Student
Cleveland Clinic Lerner College of Medicine
Cleveland, OH
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, December 31, 2023, to December 30, 2024.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Nikhil Das, MD
No relevant financial relationships to disclose.
Jonathan Markle, MD
No relevant financial relationships to disclose.
Priya Shukla, BS
No relevant financial relationships to disclose.
Rishi P. Singh, MD
Consultant: Alcon, Apellis, AsclepiX, Bausch + Lomb, Genentech, Gyroscope, IVERIC bio, Novartis, Regeneron
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com